Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083226
Status:
COMPLETED
Last Update Posted:
2014-10-30
First Post:
2004-05-14
Brief Title:
Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Adult Primary Liver Cancer |
| Adult Primary Hepatocellular Carcinoma |
| Advanced Adult Primary Liver Cancer |
| Localized Unresectable Adult Primary Liver Cancer |